Protocol for a pilot study of an online (eHealth) intervention to reduce heart disease risk in male taxi drivers
Not Applicable
- Conditions
- Prevention of cardiovascular disease in male taxi driversCirculatory System
- Registration Number
- ISRCTN29693943
- Lead Sponsor
- Queen's University Belfast
- Brief Summary
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36104740/ (added 15/09/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
1. Adult males (18 years or older)
2. Working either part-time or full-time as a taxi driver in Northern Ireland
3. Must have access to the internet and have a smartphone that allows for the downloading of mobile applications
4. Able to consent to participate
5. Able to understand and comprehend English
Exclusion Criteria
1. Children and young adults (younger than 18 years old)
2. Female gender
3. No access to the internet or a smartphone that would allow for the downloading of a mobile applications
4. Unable to consent to participate
5. Unable to understand and comprehend English
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility related outcomes:<br>1. Recruitment and retention rates<br>Measured by identifying the number of participants taking part in the study (from start to end) and number of participants who withdraw from the study at any point.<br>2. Engagement with the intervention<br>Engagement rates will be assessed by program usage. Analytics will be retrieved weekly, including the amount of times a participant logs into the program, how many modules they access, how long they spend on each module and how frequently they access the progress tracking page<br>3. Usability and participant satisfaction<br>Obtained as part of a process evaluation through telephone interviews with a subset of participants following the 7-week assessment time point, as well as a satisfaction survey completed by all participants during the 3-month assessment time point.
- Secondary Outcome Measures
Name Time Method Assessed at baseline, 7 weeks, and 3 months<br>1. Clinical indices<br>1.1 CVD biomarkers (cholesterol and glucose) measured using the Alere Cholestech LDX Analyzer<br>1.2 Blood pressure (sphygmomanometer)<br>1.3 BMI (kg/m²)<br>1.4 Body fat percentage (bioelectrical impedance analysis)<br>1.5 Waist circumference (cm) (measuring tape)<br>2. Physical activity (Actigraph GT3X+ accelerometer and the International Physical Activity Questionnaire (IPAQ-SF))<br>3. Psychosocial measures<br>3.1 Health related quality of life (12-item Short Form Health Survey (SF-12))<br>3.2 Self-efficacy (General Self-Efficacy Scale (GSE))<br>3.3 Social support Multidimensional Scale of Perceived Social Support (MSPSS))